September 3, 2019 / 5:05 AM / 18 days ago

BRIEF-Santhera Pharmaceuticals H1 Net Loss Narrows To CHF 26.9 Million

Sept 3 (Reuters) - Santhera Pharmaceuticals Holding AG :

* 1H-2019 SALES ON TRACK WITH CHF 18.3 MILLION, AN INCREASE OF 14% COMPARED TO 1H-2018

* H1 OPERATING EXPENSES OF CHF 38.2 MILLION (1H-2018: CHF 39.9 MILLION)

* H1 OPERATING RESULT OF CHF -22.4 MILLION (1H-2018: CHF -26.3 MILLION)

* FULL-YEAR SALES GUIDANCE OF CHF 25-27 MILLION

* H1 NET RESULT OF CHF -26.9 MILLION (1H-2018: CHF -27.4 MILLION) Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below